Press Release: AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event

Dow JonesDec 19 17:01 ET

AngioDynamics, Inc. (NASDAQ:ANGO) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Simply Wall StDec 13 05:36 ET

AngioDynamics Analyst Ratings

BenzingaDec 10 12:28 ET · Ratings

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife

Zacks Dec 10 10:35 ET

H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsDec 10 07:31 ET · Ratings

Institutional Investors Have a Lot Riding on AngioDynamics, Inc. (NASDAQ:ANGO) With 74% Ownership

Simply Wall StDec 10 05:32 ET